John M. Bedtelyon

Array ( [id] => 9227638 [patent_doc_number] => 08633306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'SiRNA targeting histamine receptor H1' [patent_app_type] => utility [patent_app_number] => 13/136780 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 35757 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13136780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790554 [patent_doc_number] => 20120052110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'METHODS AND COMPOSITIONS FOR PROMOTING WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 13/197833 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16916 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052110.pdf [firstpage_image] =>[orig_patent_app_number] => 13197833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754674 [patent_doc_number] => 20120027791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'ANTISENSE COMPOUND FOR INDUCING IMMUNOLOGICAL TOLERANCE' [patent_app_type] => utility [patent_app_number] => 13/187338 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14807 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027791.pdf [firstpage_image] =>[orig_patent_app_number] => 13187338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778921 [patent_doc_number] => 20120041184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 13/179785 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 69686 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041184.pdf [firstpage_image] =>[orig_patent_app_number] => 13179785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757142 [patent_doc_number] => 20120029050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO DIACYLGLYCEROL ACYLTRANSFERASE 1' [patent_app_type] => utility [patent_app_number] => 13/177457 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15402 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029050.pdf [firstpage_image] =>[orig_patent_app_number] => 13177457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712316 [patent_doc_number] => 20120004403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 13/165635 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 66132 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13165635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254656 [patent_doc_number] => 08618072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease' [patent_app_type] => utility [patent_app_number] => 13/162226 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 28 [patent_no_of_words] => 10680 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7755727 [patent_doc_number] => 20120028348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'MULTIPLE RNA POLYMERASE III PROMOTER EXPRESSION CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 13/160774 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22274 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028348.pdf [firstpage_image] =>[orig_patent_app_number] => 13160774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8990468 [patent_doc_number] => 20130217749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'MODULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE-MITCHONDRIAL (PEPCK-M) EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/702965 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28989 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8430993 [patent_doc_number] => 20120252867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'METHOD OF THERAPY AND DIAGNOSIS OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 13/152520 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 7748 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13152520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10559589 [patent_doc_number] => 09283243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'CD36 inhibition to control obesity and insulin sensitivity' [patent_app_type] => utility [patent_app_number] => 13/701726 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7820 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8241012 [patent_doc_number] => 20120149754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'METHODS FOR MODULATING THE EXPRESSION AND AGGREGATION OF CAG-EXPANDED GENE PRODUCT IN CELLS AND METHODS FOR IDENTIFYING AGENTS USEFUL FOR DOING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/110494 [patent_app_country] => US [patent_app_date] => 2011-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6106 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13110494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937718 [patent_doc_number] => 20110213014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/107131 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21966 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213014.pdf [firstpage_image] =>[orig_patent_app_number] => 13107131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056249 [patent_doc_number] => 20120077868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Use of Toll-like receptor-9 agonists, Toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of Toll-like receptor-4-associated disorders' [patent_app_type] => utility [patent_app_number] => 13/068553 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 11798 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077868.pdf [firstpage_image] =>[orig_patent_app_number] => 13068553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099371 [patent_doc_number] => 08563243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Methods for affecting homology-directed DNA double stranded break repair' [patent_app_type] => utility [patent_app_number] => 13/105258 [patent_app_country] => US [patent_app_date] => 2011-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 3654 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13105258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8828673 [patent_doc_number] => 20130129719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'HER2 NUCLEIC ACID APTAMERS' [patent_app_type] => utility [patent_app_number] => 13/697498 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22949 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232820 [patent_doc_number] => 08198258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases' [patent_app_type] => utility [patent_app_number] => 13/092501 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18152 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198258.pdf [firstpage_image] =>[orig_patent_app_number] => 13092501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488069 [patent_doc_number] => 20110251261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION' [patent_app_type] => utility [patent_app_number] => 13/085878 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 44020 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251261.pdf [firstpage_image] =>[orig_patent_app_number] => 13085878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846275 [patent_doc_number] => 08455455 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-06-04 [patent_title] => 'Compositions and methods for silencing genes involved in hemorrhagic fever' [patent_app_type] => utility [patent_app_number] => 13/077856 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 77528 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13077856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8637096 [patent_doc_number] => 20130028899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'TREATMENT OF CANCER BY INHIBITING ACTIVITY OR EXPRESSION OF LATE SV-40 FACTOR' [patent_app_type] => utility [patent_app_number] => 13/636815 [patent_app_country] => US [patent_app_date] => 2011-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 15327 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636815 [rel_patent_id] =>[rel_patent_doc_number] =>)